3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
80
Neoplasm Metastasis
6
Neoplasms
3
Breast Neoplasms, Male
3
Arthralgia
2
Triple Negative Breast Neoplasms
1
Sleep Wake Disorders
1
Skin Diseases
1
Prostatic Neoplasms
1
Post Menopausal Women With Early Breast Cancer
1
Pancreatic Neoplasms
1
Pain
1
Ovarian Neoplasms
1
Obesity
1
Metastatic Beast Cancer
1
Mammary Neoplasms, Animal
1
Lymphoma
1
Lethal Congenital Contracture Syndrome 2
1
Invasive Early Breast Cancer
1
Human Epidermal Growth Factor 2 Negative Carcinoma of Breast
1
Fatigue
1
Estrogen-receptor Positive Invasive Metastatic Breast Cancer
1
Endometrial Neoplasms
1
Endometrial Hyperplasia
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Intraductal, Noninfiltrating
1
Breast Diseases
1
Breast Carcinoma In Situ
1
Breast Cancer Metastatic
1
Advanced Breast Carcinoma
1
Interventions
Cisplatin
32
human papillomavirus vaccine, L1 type 16, 18
16
Brachytherapy
15
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
12
Paclitaxel
11
Bevacizumab
11
pembrolizumab
10
Platinum
9
1,2-diaminocyclohexaneplatinum II citrate
9
Topotecan
8
Radiotherapy, Intensity-Modulated
8
Radiation
8
Papillomavirus Vaccines
8
atezolizumab
6
Gemcitabine
6
Fluorodeoxyglucose F18
6
Cyclophosphamide
6
tisotumab vedotin
5
fludarabine phosphate
5
fludarabine
5
aldesleukin
5
Taxes
5
Radiotherapy
5
Magnetic Resonance Spectroscopy
5
Carboplatin
5
Vaccines, Synthetic
4
Nivolumab
4
Immunoglobulin G
4
Disulfides
4
Colposcopy
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Uterine Cervical Neoplasms
×
exemestane
×
Clear all
No trials found.